NHY-32332-96028
1 vaccination
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 294 / SC
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-19
Registered in v-safe
-
2021-08-19
Dose 1 — Pfizer-BioNTech
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-09-02
-
2021-09-09
Survey response — day 21, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend schoolFree text: Headache, sore throat, fatigue, runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-16
- 2021-09-23
- 2021-11-18
- 2022-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-19 | Pfizer-BioNTech | No |
Free text
Release 9 — day 21, dose 1
Symptoms: Headache, sore throat, fatigue, runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release